Rituximab Superior to Azathioprine in Prevention of Relapse in ANCA-Associated Vasculitis
Rheumatology Advisor,
Repeat-dose rituximab was found to be superior to daily azathioprine in preventing relapse in patients with a prior history of…
Repeat-dose rituximab was found to be superior to daily azathioprine in preventing relapse in patients with a prior history of…
Improvements in disease activity were found to be comparable among patients with rheumatoid arthritis (RA) who received…